Last updated on April 19, 2014 at 17:21 EDT

Elsevier Announces the Winner of the 2013 Tetrahedron Prize

October 22, 2013

AMSTERDAM, October 22, 2013 /PRNewswire/ –

Professor Shankar Balasubramanian from the University of Cambridge, UK is
awarded the 2013 Tetrahedron Prize for his outstanding contributions to nucleic acid

chemistry and biology

Elsevier [http://www.elsevier.com ] and the Executive Board of Editors of the
Tetrahedron journal series are pleased to announce that the 2013 Tetrahedron Prize for
Creativity in Organic Chemistry & BioMedicinal Chemistry
[http://www.elsevier.com/physical-sciences/chemistry/organic-chemistry/tetrahedron-prize-for-creativity-in-organic-chemistry-or-bioorganic-medicinal-chemistry ]
has been awarded to
Professor Shankar Balasubramanian.

The annual Tetrahedron Prize honors the most creative and influential organic or
medicinal chemist. The Executive Board of Editors of the Tetrahedron journal series
selected Professor Balasubramanian for his many highly significant and seminal
contributions to nucleic acid chemistry and biology.

Professor Stephen Neidle, Chairman of the Editorial Board of Tetrahedron journals,
said, “Professor Balasubramanian is a world-leading researcher in the study of quadruplex
nucleic acids, demonstrating, for example, the existence of these structures in human
cells: a landmark study which can pave the way to therapeutic targeting of quadruplexes.
Furthermore, he has creatively applied knowledge of nucleic acid chemistry to the
invention of next-generation DNA sequencing which is revolutionizing genetics and its
application to medicine.”

“I am deeply honoured to be the recipient of this important prize and to join such a
distinguished collection of chemists who have previously received this award,” said
Professor Balasubramanian. “I would like to acknowledge the contributions of many talented
and visionary co-workers and collaborators with whom it continues to be a great pleasure
exploring nature through science. I thank Tetrahedron journals and the election committee
for recognising the importance of the field of nucleic acids. I foresee that chemistry
will contribute many more discoveries and inventions to further our understanding of DNA
and RNA in the next decade and beyond.”

Diddel Francissen, Executive Publisher of Tetrahedron journal series at Elsevier,
said, “I am delighted with the choice of Professor Balasubramanian as the winner of the
2013 Tetrahedron Prize. I thank both the nominators and the leading scientists in the
voting committee, who helped the Editors in making such an exceptional choice from a field
of very strong nominations.”

The Tetrahedron Prize consists of a gold medal and a monetary award of $10,000 and
will be presented to Professor Shankar Balasubramanian at the Fall 2014 ACS National
Meeting [http://www.acs.org/content/acs/en/meetings/nationalmeetings/meetings.html ] in
San Francisco, USA (10-14 August 2014).

About Professor Shankar Balasubramanian

Shankar Balasubramanian was born in Madras (now Chennai) India in 1966 and moved to
the UK with his parents in 1967. He grew up in a rural area just outside Runcorn in
Cheshire and was schooled at Daresbury (primary), then Appleton Hall High School
(secondary). He did his undergraduate degree in Natural Sciences at the University of
Cambridge (1985-88) and then carried out a PhD under the supervision of Professor Chris
Abell (1988-1991). Balasubramanian then traveled to the USA as a SERC/NATO Research Fellow
and worked in the group of Professor Steven J Benkovic at Pensylvannia State University
(1991-1993). He started his independent academic career in 1994 in the University of
Cambridge and has remained there ever since. He is currently the Herchel Smith Professor
of Medicinal Chemistry and holds a joint appointment between the Clinical School and
Department of Chemistry. He directs research laboratories in the Department of Chemistry
and also the Cambridge Research Institute at the Addenbrookes Biomedical Campus.

More information:


About the Tetrahedron Prize

The Tetrahedron Prize for Creativity in Organic Chemistry was established in 1980 by
the Executive Board of Editors and the Publisher of Tetrahedron Publications. It is
intended to honor the memory of the founding co-Chairmen of these publications, Professor
Sir Robert Robinson and Professor Robert Burns Woodward.

The Tetrahedron Prize is awarded on an annual basis for creativity in Organic
Chemistry or Bioorganic and Medicinal Chemistry. The prize consists of a gold medal, a
certificate, and a monetary award of US $10,000. It is awarded to an Organic or Medicinal
Chemist who has made significant original contributions to the field, in its broadest
sense. On some occasions, the Prize may be awarded jointly to two winners in which case
two medals are presented. The winner is expected to write an appropriate article for
Tetrahedron or Bioorganic & Medicinal Chemistry as part of a Symposium-in-Print compiled
in their honor.

For more information:


About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], SciVal [http://info.scival.com ], Reaxys
[http://www.elsevier.com/reaxys ], ClinicalKey [https://www.clinicalkey.com ] and Mosby’s
Suite [http://www.confidenceconnected.com ], which enhance the productivity of science and
health professionals, helping research and health care institutions deliver better
outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com/Pages/Home.aspx ], a world leading provider of professional
information solutions. The group employs more than 30,000 people, including more than
15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies,
Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam
and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam:
REN; New York: RUK and ENL.

        Media contact
        Darren Sugrue

SOURCE Elsevier

Source: PR Newswire